stockrowEdwards Lifesciences Corporation
Edwards Lifesciences Corporation’s revenue for fiscal 2025 (year ended December 2025) was $6.1 billion, up 11.5% from fiscal 2024.
- Revenue
- +10.5%
- EPS
- +6.00%
- Free cash flow
- −1.84%
- Total debt
- +0.10%
Quarter to September 2026, against a year earlier
Follow EW
Alert me
Edwards Lifesciences Corporation (EW) Current ratio
Edwards Lifesciences Corporation's current ratio at the end of the quarter to 30 September 2026 was 4.6×, up 0.9× from fiscal 2025 (3.7×). Over the past ten years it has ranged from 1.8× (fiscal 2017) to 4.3× (fiscal 2015); the current reading is higher than 73% of that period. That is above the Medical Devices industry median of 2.7× and above the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 3.7× | (11.02%) |
| FY2024 | 4.2× | 23.69% |
| FY2023 | 3.4× | 11.49% |
| FY2022 | 3.0× | (1.73%) |
| FY2021 | 3.1× | (10.89%) |
| FY2020 | 3.5× | 4.57% |
| FY2019 | 3.3× | 26.75% |
| FY2018 | 2.6× | 45.32% |
| FY2017 | 1.8× | (57.32%) |
| FY2016 | 4.2× | (2.18%) |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 4.6× | 1.65% |
| Jun 2026 | 4.5× | 2.29% |
| Mar 2026 | 4.4× | 18.98% |
| Dec 2025 | 3.7× | (7.21%) |
| 43 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| EW Edwards Lifesciences Corporation | 4.6× |
| SYK Stryker Corporation compare | 2.2× |
| MDT Medtronic PLC compare | 2.1× |
| STE STERIS plc compare | 2.1× |
| DXCM DexCom, Inc. compare | 1.7× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 1.5× |
| BSX Boston Scientific Corporation compare | 1.4× |
| PHG Koninklijke Philips N.V. compare | 1.3× |
| GEHC GE HealthCare Technologies Inc. compare | 1.3× |
| Medical Devices industry median | 2.7× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on EW
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement